{
Abbott Laboratories

Companies

}
001122334455554433221100
001122334455554433221100

ubs highlights top 30 stock picks for q1 2025 across sectors

UBS's CIO Americas wealth management team has identified its top 30 stock picks from S&P sectors as Q1 2025 concludes. Notable selections include Boeing, Coca-Cola, Home Depot, and Exxon Mobil, alongside tech and healthcare leaders like Meta, Nvidia, and UnitedHealth Group. The analysis emphasizes value, growth, profitability, earnings revisions, and price momentum to highlight stocks likely to outperform their sector benchmarks in the coming year.
Yahoo Finance
The Home Depot, Inc. NVIDIA Corporation Boeing Co Salesforce, Inc. Abbott Laboratories Exxon Mobil Corp Coca-Cola FEMSA, S.A.B. de C.V. UnitedHealth Group Inc NextEra Energy, Inc. Micron Solutions, Inc. USA Show more
Business & Industry, Market Report
14:23 01.04.2025

ubs highlights top 30 stock picks for q1 2025 across sectors

UBS's CIO Americas wealth management team has identified its top 30 stock picks from S&P sectors as Q1 2025 concludes. Notable selections include Boeing, Coca-Cola, Home Depot, Exxon Mobil, Meta, Nvidia, Salesforce, and UnitedHealth Group. The analysis emphasizes value, growth, profitability, earnings revisions, and price momentum to highlight stocks likely to outperform their sector benchmarks in the coming year.
@gurufocus
The Home Depot, Inc. NVIDIA Corporation Boeing Co Salesforce, Inc. Abbott Laboratories Exxon Mobil Corp Coca-Cola FEMSA, S.A.B. de C.V. UnitedHealth Group Inc NextEra Energy, Inc. Micron Solutions, Inc. USA Show more
Business & Industry, Market Report
13:23 01.04.2025

elon musk's x files antitrust lawsuit against major advertisers over boycott

Elon Musk's X has expanded its lawsuit against several companies, including Lego and Shell, alleging they conspired to boycott the platform and violate antitrust laws. The complaint claims that members of the Global Alliance for Responsible Media collectively withheld advertising revenue and enforced brand safety standards that X has since met or exceeded. The lawsuit highlights the ongoing impact of this boycott on the platform's revenue and its contentious relationship with advertisers since Musk's acquisition.
USA TODAY
Abbott Laboratories Tyson Foods, Inc. Colgate-Palmolive Co Nestle SA Pinterest, Inc. SHELL International B.V. Linda Yaccarino Elon Musk Show more
Regulatory & Legal, News Article
19:19 02.02.2025

abbott laboratories maintains strong market position with diverse product offerings

Abbott Laboratories focuses on the research, development, manufacture, and marketing of pharmaceutical and medical products, with net sales primarily from diagnostic systems (39.1%) and vascular devices (24.7%). The company generates 38.5% of its sales in the United States, with significant contributions from Germany (5.8%), China (5.6%), and India (4.4%). Other product categories include nutritional products (12.1%) and medical products (8.2%).
MarketScreener
United States Dollar Abbott Laboratories USA DEU NLD JPN CHN IND CHE Show more
Business & Industry, Market Report
17:03 23.01.2025

abbott laboratories sees increased institutional investment and positive analyst ratings

Dundas Partners LLP and Sequoia Financial Advisors LLC have increased their stakes in Abbott Laboratories, with Dundas now holding 330,227 shares worth $34.3 million and Sequoia owning 193,764 shares valued at $22.1 million. Hedge funds and institutional investors own 75.18% of the stock. Analysts have set a new price target of $148.00 for Abbott, indicating a potential upside of 25.68%, while the stock currently holds a "Moderate Buy" rating.
MarketBeat
Abbott Laboratories USA
Finance & Economy, Market Report
15:13 23.01.2025

ubs initiates buy rating for penumbra with strong revenue growth forecast

UBS has initiated coverage on Penumbra with a Buy rating and a price target of $305, citing a projected 14% revenue CAGR through 2029, driven by a strong product launch cycle and growth in the venous thromboembolism market. The stock, currently trading at $263.69, is expected to maintain a premium valuation in the high-growth MedTech sector, supported by a gross profit margin of 63% and a 17% revenue growth over the past year. Other analysts, including Oppenheimer and Wells Fargo, have also expressed positive outlooks on Penumbra, anticipating continued double-digit growth and successful product introductions.
in.investing.com
Abbott Laboratories EDWARDS LIFESCIENCES BOSTON SCIENTIFIC Intuitive Surgical, Inc. Inari Medical Inc Medtronic plc DexCom, Inc. Penumbra, Inc. Stryker Corporation USA Joe Biden Matthew Blackman Show more
Business & Industry, Market Report
11:02 21.01.2025

lateral flow assay market analysis trends and growth opportunities 2024 to 2031

Priya Pandey, a biotechnology graduate, excels in creating engaging content across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, providing detailed reports on sectors like food and beverages and pharmaceuticals, with insights into market dynamics and competitive strategies. The latest report on the Lateral Flow Assay Market forecasts trends and growth from 2024 to 2031, analyzing consumer behavior and regulatory factors while highlighting key players and emerging opportunities.
EIN News
United States Dollar QuidelOrtho Corporation Hologic Inc Thermo Fisher Scientific Inc. QIAGEN NV Siemens AG Abcam plc PerkinElmer Inc Danaher Corporation Eiken Chemical Co., Ltd. Becton, Dickinson and Company Merck KGaA Bio-Rad Laboratories Inc Abbott Laboratories F. Hoffmann-La Roche Ltd. Biomerieux SA FRA ARG NZL CAN TUR SAU ARE USA RUS IND AUS ESP GBR SGP BRA IRN CHN DEU MEX ITA JPN Priya Pandey Show more
Healthcare, Market Report
09:06 10.01.2025

healthy foods market poised for significant growth driven by consumer demand

The Healthy Foods Market, valued at USD 712.2 billion in 2023, is projected to grow significantly due to rising health awareness and demand for nutrient-rich, organic, and plant-based products. Key players include Nestle, Danone, and PepsiCo, as the market adapts to trends like personalized nutrition and technology integration in food delivery. Challenges such as high production costs and consumer preferences for traditional foods persist, but opportunities for growth remain robust across various regions.
openPR.com
United States Dollar The Kraft Heinz Company Mondelez International Inc Archer-Daniels-Midland Company Glanbia PLC PepsiCo Inc Nestle SA Dairy Farmers OF America Inc. General Mills Inc Herbalife Nutrition Ltd Glaxosmithkline plc Yakult Honsha Co Ltd Abbott Laboratories Danone S.A. FRA CHL TUR SAU RUS IND AUS ESP GBR AUT BEL COL DEU POL NGA ARG ARE CAN NZL USA MAR ZAF ISR NLD SGP BRA QAT CHN MEX ITA TWN JPN TUN KOR Show more
Healthcare, Market Report
09:18 07.01.2025

growth opportunities in the tuberculosis diagnostics market through 2033

The global tuberculosis diagnostics market, valued at approximately $2.05 billion in 2023, is projected to grow to $3.6 billion by 2033, driven by advancements in nucleic acid testing and increasing healthcare investments. Key opportunities lie in smear microscopy, active tuberculosis detection, and hospital diagnostics, with significant growth expected in the Asia-Pacific and North America regions. Major players include Beckton, Dickinson and Company, Qiagen, and F. Hoffmann-La Roche, collectively holding a substantial market share.
globenewswire.com
Euro United States Dollar Bio-Techne Corporation Thermo Fisher Scientific Inc. Qiagen N.V. Bio-Rad Laboratories, Inc. PerkinElmer Inc Becton, Dickinson and Company BioMerieux SA Abbott Laboratories USA Show more
Healthcare, Market Report
10:21 06.01.2025

food intolerance products market projected to reach over 22654 million by 2031

The global food intolerance products market, valued at $12.1 billion in 2020, is projected to reach $22.7 billion by 2031, driven by rising health consciousness and the prevalence of lactose intolerance and celiac disease. Lactose-free products are expected to see the highest growth, with a CAGR of 7.2%, while online sales channels are also anticipated to expand significantly. The Asia-Pacific region is set to experience the fastest growth rate, registering a CAGR of 7.1% from 2022 to 2031.
EIN News
General Mills, Inc. Abbott Laboratories The Kraft Heinz Company Nestle SA Danone S.A. Kellogg Company Mead Johnson Nutrition Company Corp. Show more
Healthcare, Market Report
13:44 03.01.2025
Trending
Subcategory
Stock Market Updates Market Analysis and Predictions Banking Regulations Finance Mergers & Acquisitions Corporate Responsibility & ESG Corporate News Industry Trends Retail and Consumer Goods Hedge Funds & Private Equity Real Estate Investments Banking & Investment Regulations AI Innovations Shareholder Activism Real Estate Investment Trusts (REITs) SEC & Financial Compliance Swiss Financial Market Supervisory Authority Economic Indicators Venture Capital Investments Bond Market & Treasury Yields Government Economic Policies
Countries:
USA CHE DEU GBR CHN AUS FRA JPN CAN ITA MEX IND NLD MOZ ESP ZAF HKG RUS IRL TWN
Companies:
UBS Group AG DEUTSCHE BANK AG Credit Suisse Group Ltd. Huawei Technologies CO. Ltd. UBS AG UBS GROUP B.V. Xiaomi Corporation Apple Inc. adidas AG Nvidia Corporation Bilfinger SE BNP Paribas Financial Markets SNC Analog Devices Inc. PUMA SE KEEFE, BRUYETTE and WOODS Inc. Microsoft Corporation Corp. Salzgitter AG Zalando SE Intuit Inc. JMP Securities LLC
Currencies:
Euro Swiss Franc United States Dollar British Pound Sterling Hong Kong Dollar Japanese Yen Australian Dollar New Zealand Dollar Filipino Peso Polish Złoty Chinese Yuan Swedish Krona Canadian Dollar Chilean Peso Offshore Chinese Yuan Thai Baht
People:
Donald Trump Elon Musk Vaneva Subeva Detelina Robin Leopold Karin Keller-Sutter Robert Krankowski Andrew Pearse Surjan Singh Gill Stacey Friedman Troy L Rohrbaugh Sergio Ermotti Olivier Calvet Warren Buffett Adrienne Yih Andrew Jones Greg Abel David Lefkowitz Sreedhar Mahamkali Michael Briest Henry N. Nassau

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.